|
DE19824922A1
(de)
|
1998-06-04 |
1999-12-09 |
Boehringer Ingelheim Pharma |
Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
|
GB9910807D0
(en)
|
1999-05-10 |
1999-07-07 |
Prometic Biosciences Limited |
Novel detoxification agents and their use
|
|
US6906067B2
(en)
|
1999-12-28 |
2005-06-14 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-α expression
|
|
AU783981C
(en)
|
2000-05-08 |
2007-05-03 |
Janssen Pharmaceutica N.V. |
HIV replication inhibitors
|
|
CA2450934A1
(en)
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
AU2002316421B2
(en)
|
2001-06-26 |
2008-05-15 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-ALPHA expression
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
ATE407678T1
(de)
|
2001-10-17 |
2008-09-15 |
Boehringer Ingelheim Pharma |
Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung
|
|
WO2003032994A2
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
|
|
JP4072615B2
(ja)
|
2002-03-05 |
2008-04-09 |
独立行政法人産業技術総合研究所 |
配位子を有する複素環化合物及びその製造方法、及びこの複素環化合物を用いる金属元素の固定化膜
|
|
JP2006508997A
(ja)
|
2002-11-28 |
2006-03-16 |
シエーリング アクチエンゲゼルシャフト |
Ｃｈｋ−、Ｐｄｋ−およびＡｋｔ−阻害性ピリミジン、それらの製造および薬剤としての使用
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7279576B2
(en)
|
2002-12-31 |
2007-10-09 |
Deciphera Pharmaceuticals, Llc |
Anti-cancer medicaments
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
CL2004000306A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidina sustituidas con indano; proceso para su preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; y su uso para el tratamiento o profilaxis de una enfermedad infecciosa.
|
|
EP1781659B1
(en)
|
2003-07-16 |
2008-11-05 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
WO2005012294A1
(en)
|
2003-07-30 |
2005-02-10 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
|
|
ATE506953T1
(de)
|
2003-08-07 |
2011-05-15 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
|
|
US7754714B2
(en)
|
2004-05-18 |
2010-07-13 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
|
PL1756084T3
(pl)
|
2004-06-04 |
2009-06-30 |
Arena Pharm Inc |
Podstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie zaburzeń z metabolizmem związanych
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
CA2592118C
(en)
|
2004-12-23 |
2015-11-17 |
Deciphera Pharmaceuticals, Llc |
Urea derivatives as enzyme modulators
|
|
BRPI0519794A2
(pt)
|
2005-01-07 |
2009-03-17 |
Hoffmann La Roche |
derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos
|
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
CN101484433A
(zh)
|
2006-02-15 |
2009-07-15 |
艾博特公司 |
新的乙酰辅酶a羧化酶(acc)抑制剂及其在糖尿病、肥胖症和代谢综合征中的应用
|
|
MX2008014618A
(es)
|
2006-05-15 |
2008-11-28 |
Irm Llc |
Composiciones y metodos para inhibidores de cinasas del receptor fgf.
|
|
RU2008152195A
(ru)
|
2006-06-15 |
2010-07-20 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
2-анилино-4-(гетероциклил)аминопиримидины, как ингибиторы протеинкиназы с-альфа
|
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US7790756B2
(en)
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
CA2673965A1
(en)
|
2006-12-28 |
2008-07-10 |
Taisho Pharmaceutical Co., Ltd. |
Pyrazolopyrimidine compound
|
|
WO2008131276A1
(en)
|
2007-04-20 |
2008-10-30 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
AU2008317057B8
(en)
|
2007-10-22 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Bicyclic Heterocycle Derivatives and their use as modulators of the activity of GPR119
|
|
US20100056524A1
(en)
|
2008-04-02 |
2010-03-04 |
Mciver Edward Giles |
Compound
|
|
PE20100087A1
(es)
|
2008-06-25 |
2010-02-08 |
Irm Llc |
Compuestos y composiciones como inhibidores de cinasa
|
|
US20110098221A1
(en)
|
2008-06-26 |
2011-04-28 |
Hong Lin |
INHIBITORS OF Akt ACTIVITY
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
NZ603525A
(en)
|
2008-06-27 |
2015-02-27 |
Celgene Avilomics Res Inc |
Pyrimidine based compound and uses thereof
|
|
JP5444365B2
(ja)
|
2008-10-29 |
2014-03-19 |
デシフェラ ファーマシューティカルズ，エルエルシー |
抗癌活性および抗増殖活性を示すシクロプロパンアミドおよび類似物質
|
|
WO2010111406A2
(en)
|
2009-03-24 |
2010-09-30 |
Myriad Pharmaceuticals, Inc. |
Compounds and therapeutic uses thereof
|
|
US8410126B2
(en)
|
2009-05-29 |
2013-04-02 |
Boehringer Ingelheim International Gmbh |
Pyrimidine inhibitors of PKTK2
|
|
TW201100441A
(en)
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
|
PH12012500097A1
(en)
*
|
2009-07-21 |
2011-01-27 |
Shanghai Inst Organic Chem |
Potent small molecule inhibitors of autophagy, and methods of use thereof
|
|
KR101445012B1
(ko)
|
2009-12-17 |
2014-09-26 |
머크 샤프 앤드 돔 코포레이션 |
Ｓｙｋ 억제제로서의 아미노피리미딘
|
|
JP2013516422A
(ja)
|
2009-12-30 |
2013-05-13 |
アビラ セラピューティクス， インコーポレイテッド |
タンパク質のリガンド−指向性共有的修飾
|
|
SG185073A1
(en)
|
2010-04-29 |
2012-12-28 |
Deciphera Pharmaceuticals Llc |
Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activites
|
|
CA2800998A1
(en)
|
2010-04-29 |
2011-11-10 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
ES2577829T3
(es)
|
2010-06-04 |
2016-07-19 |
F. Hoffmann-La Roche Ag |
Derivados de aminopirimidina como moduladores de la LRRK2
|
|
WO2012033195A1
(ja)
|
2010-09-10 |
2012-03-15 |
京都薬品工業株式会社 |
複素環化合物
|
|
NO2638031T3
(enExample)
|
2010-11-10 |
2018-03-10 |
|
|
|
US20130324532A1
(en)
|
2011-02-17 |
2013-12-05 |
Cancer Therapeutics Crc Pty Limited |
Fak inhibitors
|
|
EP2736901A1
(en)
|
2011-07-28 |
2014-06-04 |
Cellzome Limited |
Heterocyclyl pyrimidine analogues as jak inhibitors
|
|
JP2015507606A
(ja)
|
2011-11-22 |
2015-03-12 |
デシフェラ ファーマシューティカルズ，エルエルシー |
抗癌および抗増殖作用を示すピリドンアミドおよび類似体
|
|
US9145402B2
(en)
|
2011-11-29 |
2015-09-29 |
Genentech, Inc. |
Aminopyrimidine derivatives as LRRK2 modulators
|
|
MX348920B
(es)
|
2011-11-29 |
2017-07-04 |
Genentech Inc |
Derivados de 2-(fenil o pirid-3-il)aminopirimidina como moduladores de proteina cinasa 2 de repeticion rica en leucina (lrrk2) para el tratamiento de la enfermedad de parkinson.
|
|
EP2785381B1
(en)
|
2011-11-30 |
2016-05-18 |
F.Hoffmann-La Roche Ag |
Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (pet) imaging for lrrk2
|
|
CN103159736B
(zh)
*
|
2011-12-10 |
2015-05-13 |
通化济达医药有限公司 |
取代的吡唑激酶抑制剂
|
|
WO2013134298A1
(en)
|
2012-03-07 |
2013-09-12 |
Deciphera Pharmaceuticals, Llc |
Raf inhibitor compounds
|
|
AR090151A1
(es)
|
2012-03-07 |
2014-10-22 |
Lilly Co Eli |
Compuestos inhibidores de raf
|
|
GB201204384D0
(en)
|
2012-03-13 |
2012-04-25 |
Univ Dundee |
Anti-flammatory agents
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
WO2014078378A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014086102A1
(zh)
|
2012-12-06 |
2014-06-12 |
山东亨利医药科技有限责任公司 |
作为酪氨酸激酶抑制剂的吲哚满酮衍生物
|
|
US9012635B2
(en)
|
2013-03-15 |
2015-04-21 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
JP6364472B2
(ja)
|
2013-03-15 |
2018-07-25 |
デシフェラ ファーマシューティカルズ，エルエルシー |
抗がんおよび抗増殖活性を示すｎ−アシル−ｎ’−（ピリジン−２−イル）尿素および類似体
|
|
WO2014145023A1
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2014145015A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2014145029A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
DK2968286T3
(en)
|
2013-03-15 |
2018-01-02 |
Deciphera Pharmaceuticals Llc |
2-AMINOPYRIMIDIN-6-ONES AND ANALOGS THAT HAVE ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES
|
|
CN103242341B
(zh)
|
2013-04-19 |
2015-12-09 |
中国科学院广州生物医药与健康研究院 |
噻吩并2，4取代嘧啶类化合物及其药物组合物与应用
|
|
US9783504B2
(en)
|
2013-07-09 |
2017-10-10 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
|
KR101879422B1
(ko)
|
2013-09-18 |
2018-07-17 |
베이징 한미 파마슈티컬 컴퍼니 리미티드 |
Btk 및/또는 jak3 키나제의 활성을 억제하는 화합물
|
|
WO2015039613A1
(zh)
|
2013-09-18 |
2015-03-26 |
北京韩美药品有限公司 |
抑制btk和/或jak3激酶活性的化合物
|
|
PH12016500676B1
(en)
|
2013-10-18 |
2022-07-20 |
Eisai R&D Man Co Ltd |
Pyrimidine fgfr4 inhibitors
|
|
BR112016008632A8
(pt)
|
2013-10-21 |
2020-03-17 |
Merck Patent Gmbh |
compostos de heteroarila como inibidores de btk, seus usos, e composição farmacêutica
|
|
US9457019B2
(en)
|
2013-11-07 |
2016-10-04 |
Deciphera Pharmaceuticals, Llc |
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
|
|
WO2015123722A1
(en)
*
|
2014-02-19 |
2015-08-27 |
Bionomics Limited |
Inhibitors
|
|
US20150284341A1
(en)
|
2014-04-07 |
2015-10-08 |
Catylix, Inc. |
Fluoroalkyl-substituted derivatives of pyridine, pyrimidine, and pyrazine
|
|
US10266549B2
(en)
|
2014-08-25 |
2019-04-23 |
Salk Institute For Biological Studies |
ULK1 inhibitors and methods using same
|
|
CN105399685B
(zh)
|
2014-09-16 |
2018-05-22 |
深圳微芯生物科技有限责任公司 |
作为选择性jak3和/或jak1激酶抑制剂的芳杂环化合物的制备方法及其应用
|
|
EP3056202A1
(en)
|
2015-02-16 |
2016-08-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Benzopyrrolidone derivatives possessing antiviral and anticancer properties
|
|
WO2016135163A1
(en)
|
2015-02-25 |
2016-09-01 |
F. Hoffmann-La Roche Ag |
Alkynyl alcohols and methods of use
|
|
CN108348779A
(zh)
|
2015-08-02 |
2018-07-31 |
H·李·莫菲特癌症中心研究有限公司 |
Ack1/tnk2酪氨酸激酶的抑制剂
|
|
WO2017066428A1
(en)
|
2015-10-13 |
2017-04-20 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Brd4-kinase inhibitors as cancer therapeutics
|
|
BR112018008630A2
(pt)
*
|
2015-11-06 |
2018-10-30 |
Neurocrine Biosciences Inc |
derivados de n-[2-(1-benzilpiperidin-4-il)etil]-4-(pirazin-2-il)-piperazina-1-carboxamida, seus usos, composição farmacêutica
|
|
US11028080B2
(en)
|
2016-03-11 |
2021-06-08 |
Denali Therapeutics Inc. |
Substituted pyrimidines as LRKK2 inhibitors
|
|
CN108239069B
(zh)
*
|
2016-12-26 |
2021-01-05 |
南京药捷安康生物科技有限公司 |
一种用于成纤维细胞生长因子受体的抑制剂及其用途
|
|
AU2018226771B2
(en)
|
2017-02-28 |
2023-11-23 |
Dana-Farber Cancer Institute, Inc. |
Uses of pyrimidopyrimidinones as SIK inhibitors
|
|
MY205552A
(en)
|
2017-05-30 |
2024-10-25 |
Deciphera Pharmaceuticals Inc |
Use of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl ]-3-phenylurea and analogs for the treatment of cancers associated with genetic abnormalities in platelet derived growth factor receptor alpha
|
|
CN109535132B
(zh)
|
2017-09-21 |
2021-07-20 |
北京赛特明强医药科技有限公司 |
2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
|
|
IL276398B2
(en)
|
2018-01-31 |
2026-03-01 |
Deciphera Pharmaceuticals Llc |
Combination therapy for mastocytosis
|
|
EA202092305A1
(ru)
|
2018-03-27 |
2020-12-07 |
Нейропор Терапиз, Инк. |
Соединения в качестве модуляторов сигнализации tlr2
|
|
KR102803762B1
(ko)
|
2018-04-10 |
2025-05-09 |
뉴로포레 테라피스, 인코포레이티드 |
Pi3-키나제 및 오토파지 경로의 조절인자로서의 트리-치환된 아릴 및 헤테로아릴 유도체
|
|
BR112021012812A2
(pt)
|
2018-12-28 |
2021-12-07 |
Deciphera Pharmaceuticals Llc |
Csf1r inhibitors para uso e tratamento de câncer
|
|
BR112021022237A2
(pt)
|
2019-05-10 |
2022-03-29 |
Janssen Biotech Inc |
Queladores macrocíclicos e métodos de uso dos mesmos
|
|
PE20220597A1
(es)
|
2019-05-10 |
2022-04-22 |
Deciphera Pharmaceuticals Llc |
Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos
|
|
SG11202110561XA
(en)
|
2019-05-10 |
2021-10-28 |
Cersci Therapeutics Inc |
Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent
|
|
US11518758B2
(en)
|
2019-05-10 |
2022-12-06 |
Deciphera Pharmaceuticals, Llc |
Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
|
|
PE20221083A1
(es)
|
2019-06-17 |
2022-07-05 |
Deciphera Pharmaceuticals Llc |
Inhibidores de la autofagia de la amida aminopirimidina y sus metodos de uso
|
|
KR20220150270A
(ko)
|
2019-10-07 |
2022-11-10 |
칼리오페, 인크. |
Gpr119 효능제
|
|
US12458630B2
(en)
|
2020-01-14 |
2025-11-04 |
The Regents Of The University Of California |
Combination therapy for cancer
|
|
WO2023108110A2
(en)
|
2021-12-10 |
2023-06-15 |
Verastem, Inc. |
Combination therapy for treating abnormal cell growth
|